HAEMONETICS CORP Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Haemonetics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Haemonetics Corp Operating Income (Loss) for the quarter ending September 28, 2024 was $51.7M, a 46.4% increase year-over-year.
  • Haemonetics Corp Operating Income (Loss) for the twelve months ending September 28, 2024 was $167M, a 0.07% decline year-over-year.
  • Haemonetics Corp annual Operating Income (Loss) for 2023 was $165M, a 5.67% increase from 2022.
  • Haemonetics Corp annual Operating Income (Loss) for 2022 was $156M, a 93.2% increase from 2021.
  • Haemonetics Corp annual Operating Income (Loss) for 2021 was $80.8M, a 10% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $167M $51.7M +$16.4M +46.4% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-07
Q2 2024 $151M $39.8M -$13.9M -25.9% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $165M $29.9M -$5.31M -15.1% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 $170M $46M +$2.7M +6.24% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $167M $35.3M -$11.4M -24.5% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $179M $53.7M +$22.9M +74.4% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 $156M $35.3M +$16.1M +83.6% Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 $140M $43.3M +$7.63M +21.4% Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $132M $46.7M +$22.2M +90.7% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-02
Q2 2022 $110M $30.8M +$29.4M +2113% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 $80.8M $19.2M +$40.4M Jan 2, 2022 Apr 2, 2022 10-K 2024-05-20
Q4 2021 $40.4M $35.7M -$4.77M -11.8% Oct 3, 2021 Jan 1, 2022 10-Q 2023-02-07
Q3 2021 $45.2M $24.5M -$34.3M -58.3% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 $79.4M $1.39M -$10.3M -88.1% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-10
Q1 2021 $89.7M -$21.2M -$47.2M -181% Dec 27, 2020 Apr 3, 2021 10-K 2021-05-26
Q4 2020 $137M $40.4M -$482K -1.18% Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 $137M $58.8M +$9.04M +18.2% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-09
Q2 2020 $128M $11.7M +$25M Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $103M $26M +$2.15M +9.02% Dec 29, 2019 Mar 28, 2020 10-K 2021-05-26
Q4 2019 $101M $40.9M +$12.6M +44.4% Sep 29, 2019 Dec 28, 2019 10-K 2021-05-26
Q3 2019 $88.6M $49.7M +$23.7M +90.7% Jun 30, 2019 Sep 28, 2019 10-K 2021-05-26
Q2 2019 $65M -$13.3M -$18.6M -351% Mar 31, 2019 Jun 29, 2019 10-K 2021-05-26
Q1 2019 $83.5M $23.9M +$9.58M +67.1% Dec 30, 2018 Mar 30, 2019 10-K 2020-05-20
Q4 2018 $74M $28.3M +$27.3M +2696% Sep 30, 2018 Dec 29, 2018 10-K 2020-05-20
Q3 2018 $46.7M $26.1M +$1.82M +7.49% Jul 1, 2018 Sep 29, 2018 10-K 2020-05-20
Q2 2018 $44.8M $5.29M -$11.3M -68.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-05-20
Q1 2018 $56.2M $14.3M +$71.8M Dec 31, 2017 Mar 31, 2018 10-K 2019-05-22
Q4 2017 -$15.6M $1.01M -$20.2M -95.2% Oct 1, 2017 Dec 30, 2017 10-K 2019-05-22
Q3 2017 $4.58M $24.3M -$536K -2.16% Jul 2, 2017 Sep 30, 2017 10-K 2019-05-22
Q2 2017 $5.11M $16.6M +$24.5M Apr 2, 2017 Jul 1, 2017 10-K 2019-05-22
Q1 2017 -$19.4M -$57.5M -$52M -936% Jan 1, 2017 Apr 1, 2017 10-K 2018-05-23
Q4 2016 $32.6M $21.2M +$82.4M Oct 2, 2016 Dec 31, 2016 10-K 2018-05-23
Q3 2016 -$49.8M $24.8M +$5.62M +29.3% Jul 3, 2016 Oct 1, 2016 10-K 2018-05-23
Q2 2016 -$55.4M -$7.88M -$11.5M -319% Apr 3, 2016 Jul 2, 2016 10-K 2018-05-23
Q1 2016 -$43.9M -$5.55M -$17.1M -148% Dec 27, 2015 Apr 2, 2016 10-K 2017-05-24
Q4 2015 -$26.9M -$61.2M -$79.4M -435% Sep 27, 2015 Dec 26, 2015 10-K 2017-05-24
Q3 2015 $52.6M $19.2M +$6.77M +54.6% Jun 28, 2015 Sep 26, 2015 10-K 2017-05-24
Q2 2015 $45.8M $3.61M +$5.27M Mar 29, 2015 Jun 27, 2015 10-K 2017-05-24
Q1 2015 $40.5M $11.5M -$827K -6.69% Dec 28, 2014 Mar 28, 2015 10-K 2016-06-01
Q4 2014 $41.4M $18.3M +$706K +4.02% Sep 28, 2014 Dec 27, 2014 10-K 2016-06-01
Q3 2014 $40.7M $12.4M -$10.7M -46.3% Jun 29, 2014 Sep 27, 2014 10-K 2016-06-01
Q2 2014 $51.4M -$1.67M +$4.94M +74.8% Mar 30, 2014 Jun 28, 2014 10-K 2016-06-01
Q1 2014 $46.4M $12.4M -$5.34M -30.2% Dec 29, 2013 Mar 29, 2014 10-K 2015-05-22
Q4 2013 $51.8M $17.6M +$1.81M +11.5% Sep 29, 2013 Dec 28, 2013 10-K 2015-05-22
Q3 2013 $50M $23.1M +$13.2M +134% Jun 30, 2013 Sep 28, 2013 10-K 2015-05-22
Q2 2013 $36.8M -$6.61M -$19.7M -151% Mar 31, 2013 Jun 29, 2013 10-K 2015-05-22
Q1 2013 $56.4M $17.7M -$3.25M -15.5% Dec 30, 2012 Mar 30, 2013 10-K 2014-05-22
Q4 2012 $59.7M $15.7M -$9.58M -37.8% Sep 30, 2012 Dec 29, 2012 10-K 2014-05-22
Q3 2012 $69.3M $9.9M -$8.67M -46.7% Jul 1, 2012 Sep 29, 2012 10-K 2014-05-22
Q2 2012 $77.9M $13.1M -$10.8M -45.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-05-22
Q1 2012 $88.8M $21M -$7.94M -27.5% Jan 1, 2012 Mar 31, 2012 10-K 2013-05-20
Q4 2011 $96.7M $25.3M -$3.24M -11.3% Oct 2, 2011 Dec 31, 2011 10-K 2013-05-20
Q3 2011 $99.9M $18.6M -$10.3M -35.8% Jul 3, 2011 Oct 1, 2011 10-K 2013-05-20
Q2 2011 $110M $23.9M -$281K -1.16% Apr 3, 2011 Jul 2, 2011 10-K 2013-05-20
Q1 2011 $111M $28.9M Jan 2, 2011 Apr 2, 2011 10-K 2012-05-22
Q4 2010 $28.6M Oct 3, 2010 Jan 1, 2011 10-K 2012-05-22
Q3 2010 $28.9M Jul 4, 2010 Oct 2, 2010 10-K 2012-05-22
Q2 2010 $24.2M Apr 4, 2010 Jul 3, 2010 10-K 2012-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.